Govt moves to step-up Covaxin production April 16, 2021 × Ropes in 3 govt units, funds upgrade of Bharat Bio facility to raise monthly output to 10 cr doses by Sept The Government has unveiled a plan to expand the manufacture of indigenous vaccine, Covaxin. The aim is to make 10 crore doses a month, by September. The plan involves upgrading Hyderabad-based Bharat Biotech Ltd, which produces Covaxin, besides building-up the production capacities of public sector manufacturers — Haffkine Biopharmaceutical Corp, Indian Immunologicals Ltd, and Bharat Immunologicals & Biologicals Corporation — with infrastructure and technology. The current production capacity will be doubled by May-June and then increased 6-7 fold by July-August. Thta is, production will be stepped up from 1 crore doses in April to 6-7 crore vials per month in July-August. It is likely to reach nearly 10 crore doses per month by September under the government’s Mission Covid Suraksha, the Health Ministry said in a release on Friday.